Skip to main content

Table 1 Overview of Study Characteristics

From: Nurse-led interventions in systemic autoimmune rheumatic diseases: a systematic review

Author, year, country

SARD

Sample size

Sample characteristics

   

Age

Mean (SD)

Female

N (%)

Race/ethnicity

N (%)

Marital status

N (%)

Disease duration

Mean (SD)

Kankaya & Karadakovan (2020); Turkey

SLE

Total = 80

Control = 40

Intervention = 40

Control: 39.0 (12.7)

Intervention: 35.6 (8.4)

Control: 38 (95%)

Intervention: 38 (95%)

N/S

N/S

Control:✝

< 1 yrs: 2 (5%)

1–10 yrs: 21 (52.5%)

11–20 yrs: 13 (32.5%)

> 20 yrs: 4 (10%)

Intervention:✝

< 1 yrs: 3 (7.5%)

1–10 yrs: 23 (57.5%)

11–20 yrs: 11 (27.5%)

> 20 yrs: 3 (7.5%)

Karlson et al. (2004); US

SLE

Total = 122

Control = 58

Intervention = 64

Control: 40.8 (11.1)

Intervention: 42.7 (22.8)

Control: 56 (98%)

Intervention: 63 (98%)

White:

Control: 48 (84%)

Intervention: 57 (89%)

N/S

N/S

Uras et al. (2019); Italy

Systemic sclerosis

Total = 63

Control = 31

Intervention = 32

Control: 55.2 (13.3)

Intervention: 54.6 (15.8)

100%

N/S

Control: 18 (58.1%)

Intervention: 21 (65.6%)

Control: 11.8 yrs (8.4)

Intervention: 8.7 yrs (6.3)

Wu et al. (2018); Taiwan

SLE

Total = 76

Control = 38

Intervention = 38

Control: 43.5 (12.7)

Intervention: 43.8 (9.9)

100%

N/S

Control: 22 (57.9%)

Intervention: 29 (76.3%)

Control: 12.3 yrs (8.4)

Intervention: 12.0 yrs (7.4)

Xie et al. (2018); China

SLE

Total = 125

Control = 61

Intervention = 64

Control: 38.4 (15.8)

Intervention: 35.9 (12.3)

Control: 54 (88.5%)

Intervention: 57 (89.1%)

N/S

Control: 47 (77%)

Intervention: 45 (70.3%)

Control:

≤ 3 yrs = 30 (49.2)

> 3 yrs = 31 (50.8)

Intervention:

≤ 3 yrs = 33 (51.6)

> 3 yrs = 31 (48.4)

  1. Note. SARD = systemic autoimmune rheumatic disease; SLE = systemic lupus erythematosus; N/S = not stated; yrs. = years; ✝ = data are shown as N (%) instead of mean (SD)